For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome.
Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) corresponding to Human Cyclin A2 aa 400-500 (C terminal).
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
A trial size is available to purchase for this antibody.
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.
Our Abpromise guarantee covers the use of ab32386 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Ab32386, at a 1/50 dilution, staining Cyclin A2 in paraffin embedded skin carcinoma tissue sections by Immunohistochemistry.Ab32386, at a 1/50 dilution, staining Cyclin A in paraffin embedded skin carcinoma tissue sections by Immunohistochemistry.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"